Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1057 studies found for:    Open Studies | "Carcinoma, Bronchogenic"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Carcinoma, Bronchogenic"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting SAS in Patients With Bronchial Carcinoma
Conditions: Sleep Apnea Syndrome;   Bronchial Carcinoma
Intervention: Device: sleep apnea screening with ApneaLinkTM
2 Recruiting Clinic Study of 18F-Al-NOTA-PRGD2 in Cancer Diagnostics
Conditions: Tumors;   Carcinoma, Bronchogenic;   Breast Carcinoma;   Cancer of Head and Neck;   Lymphoma, Malignant;   Soft Tissue Neoplasms
Intervention: Drug: 18F-Al-NOTA-PRGD2 PET/CT
3 Not yet recruiting Prevalence of Sleep-disordered Breathing in Patients With a Newly Diagnosed Non Small Cell Lung Cancer
Condition: Bronchial Cancer
Intervention: Device: With and without SDB
4 Unknown  Efficacy and Safety Study of Gefitinib in Squamous NSCLC Patients Who Failed First-Line Chemotherapy
Condition: Squamous Cell Carcinoma of Bronchus
Intervention: Drug: Gefitinib
5 Unknown  Study to Determine the Efficacy of Bendamustin in Patients With Recurrent Small Cell Lung Cancer (SCLC)
Condition: Recurrent Small Cell Lung Cancer
Intervention: Drug: Bendamustin/Ribomustin
6 Not yet recruiting Durvalumab (MEDI4736) With or Without SBRT in Clinical Stage IB and II Non-small Cell Lung Cancer
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: Durvalumab;   Other: Durvalumab plus SBRT
7 Recruiting Comparison of Different Types of Surgery in Treating Patients With Early-stage Non-small Cell Lung Cancer
Conditions: Stage IA Non-small Cell Lung Cancer;   Adenocarcinoma of the Lung;   Squamous Cell Lung Cancer
Intervention:
8 Recruiting Phase I Trial of Afatinib (BIBW 2992) and Dasatinib in Non-small Cell Lung Cancer (NSCLC)
Conditions: Lung Cancer;   Non-small Cell Lung Cancer (NSCLC)
Interventions: Drug: Dasatinib - 1A;   Drug: Afatinib - 1A;   Drug: Dasatinib - 1B;   Drug: Afatinib - 1B
9 Not yet recruiting A Dose Finding and Expansion Study of RO7051790 Administered Orally in Participants With Relapsed, Extensive-Stage Disease Small Cell Lung Cancer (ED SCLC)
Condition: Small Cell Lung Cancer
Intervention: Drug: RO7051790
10 Recruiting Suction on Post-Operative Chest Tubes
Condition: Non-small Cell Lung Cancer
Interventions: Device: Suction is set to -2 cmH2O;   Device: Suction is set to -10 cmH2O
11 Recruiting Real-Life Study With Nivolumab (BMS-936558) in Advanced NSCLC Patients After Prior Chemotherapy
Condition: Non-Small Cell Lung Cancer
Intervention:
12 Recruiting Continuation Study of Entinostat in Combination With Pembrolizumab in Patients With Advanced Solid Tumors
Conditions: Neoplasms;   Neoplasms, Glandular and Epithelial;   Neoplasms by Histologic Type;   Bronchial Neoplasms;   Lung Neoplasms;   Respiratory Tract Neoplasms;   Thoracic Neoplasms;   Digestive System Neoplasms;   Endocrine Gland Neoplasms;   Carcinoma, Non-Small-Cell Lung;   Lung Diseases;   Breast Diseases;   Renal Neoplasm;   Solid Tumors
Interventions: Drug: Entinostat;   Drug: Pembrolizumab
13 Not yet recruiting Study to Assess the Effect of Osimertinib (TAGRISSO™ ) on Blood Levels of Fexofenadine in Patients With EGFRm+ NSCLC
Condition: Non Small Cell Lung Cancer
Interventions: Drug: Fexofenadine tablet dosing;   Drug: Osimertininb tablet dosing
14 Not yet recruiting Urinary Circulating Tumor DNA Detection in Non-small Cell Lung Cancer: a Prospective Study
Conditions: Carcinoma;   Non-small-cell Lung Cancer;   Lung Neoplasms
Intervention:
15 Recruiting Concordance of Inivata Liquid Biopsy With Standard of Care Tissue Testing
Condition: Non-Small Cell Lung Cancer
Intervention:
16 Not yet recruiting Memory and MRI Changes With Hippocampus Avoidance Prophylactic Cranial Irradiation(HA-PCI) for Small Cell Lung Cancer(SCLC)
Condition: Small Cell Lung Cancer
Intervention: Radiation: hippocampus avoidance
17 Not yet recruiting First Line Bio-immunotherapy With Thymosin Alpha 1 in Patients With Sensitizing EGFR Mutation Positive Non Small Cell Lung Cancer Who Are Taking Standard of Care Therapy
Condition: EGFR Mutation Positive Non Small Cell Lung Cancer
Interventions: Drug: Thymalfasin (Thymosin alpha 1, Ta1);   Drug: SoC (tyrosine kinase inhibitor)
18 Not yet recruiting Thymosin Alpha 1 Plus Maintenance Therapy With the Standard of Care (SoC) in Patients With Metastatic Non-Small Cell Lung Cancer (NSCLC), EGFR Wild Type
Condition: Non-Small Cell Lung Cancer
Interventions: Drug: Thymalfasin (Thymosin alpha 1, Ta1);   Drug: SoC (chemotherapy and platinum agent)
19 Not yet recruiting A Phase 2 Study Adding Ascorbate to Chemotherapy and Radiation Therapy for NSCLC
Conditions: Carcinoma, Non-Small-Cell Lung;   Non-Small Cell Lung Cancer;   Nonsmall Cell Lung Cancer;   Non-Small-Cell Lung Carcinoma;   NSCLC
Interventions: Drug: Radiation Therapy;   Drug: Paclitaxel;   Drug: Carboplatin;   Drug: Ascorbic Acid
20 Recruiting Arginase Inhibitor CB-1158 in Patients With Solid Tumors
Conditions: Metastatic Cancer;   Solid Tumors;   Non-small Cell Lung Cancer;   Colo-Rectal Cancer;   Gastric Cancer;   Renal Cell Carcinoma;   Squamous-cell Carcinomas of the Head and Neck
Interventions: Drug: CB-1158;   Drug: Nivolumab

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years